MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
27.64
+0.61 (2.26%)
Nov 21, 2025, 1:50 PM EST - Market open
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.24 billion as of November 21, 2025. Its market cap has increased by 61.22% in one year.
Market Cap
1.24B
Enterprise Value
794.37M
1-Year Change
61.22%
Ranking
Category
Stock Price
$27.64
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.24B, an increase of 143.52%. That is a compound annual growth rate of 111.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 1.21B | 97.07% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 940.41B |
| Johnson & Johnson | 487.83B |
| AbbVie | 412.08B |
| UnitedHealth Group | 278.26B |
| AstraZeneca | 275.69B |
| Novartis AG | 244.75B |
| Merck & Co. | 235.72B |
| Abbott Laboratories | 225.60B |